A rare case of soft-tissue sarcoma spreading to the heart shows how multimodal imaging guided diagnosis and care in a 36-year-old man.
|Articles|February 17, 2018
- February 2018
- Volume 24
- Issue 2
eAppendix
Advertisement
References for: Reimbursement Landscape for Molecular Testing in Non-Small Cell Lung Cancer
Articles in this issue
over 8 years ago
Medical World News: Clinical/Managed Care Updatesover 8 years ago
Medical World News: Clinical Updatesover 8 years ago
Medical World News: Regulatory UpdatesAdvertisement
Related to this article
Sustainable models require asking what a result shows, what design produced it, and whether the design was built to measure value or just produce a number.
As AI proliferates, patients, caregivers, and others outside the medical world are using its tools to deal with cancer, but not always in obvious ways.
The 2026 COA Payer Exchange and Innovation Summit began with a panel on AI and the ever-changing digital infrastructure in community oncology.
Experts tackled CAR T access, trial equity, and overtreatment in breast cancer at an AJMC Institute for Value-Based Medicine event in San Francisco.
Advertisement
Advertisement
Trending on AJMC
1
CMS Finalizes Mandatory GLOBE Model to Test Lower Part B Drug Costs
2
Lung Cancer Screening Lags for People With HIV as Eligibility Triples
3
Dual Agonist Survodutide Delivers Up to 13.1% Weight Loss in T2D
4
VYD2311 Shows Superior Safety vs mRNA COVID-19 Vaccine
5